[1]
2021. The Contested Access to Medicines: Big Pharma Business Practices Under Criticism. PROKLA. Journal of Critical Social Science. 51, 205 (Nov. 2021), 653–671. DOI:https://doi.org/10.32387/prokla.v51i205.1970.